Literature DB >> 8106566

Thrombomodulin lacking the cytoplasmic domain efficiently internalizes thrombin via nonclathrin-coated, pit-mediated endocytosis.

E M Conway1, B Nowakowski, M Steiner-Mosonyi.   

Abstract

Thrombomodulin (TM) is a transmembrane vascular endothelial cell receptor that is a cofactor in a major physiologically relevant natural anticoagulant system. We recently developed a cell model to examine one mechanism of regulation of TM cell surface expression and visually demonstrated that the receptor undergoes internalization predominantly via noncoated pits (Conway et al., 1992, J. Cell. Phys., 151:604-612). We have extended these studies to examine the role of the cytoplasmic domain of TM by deleting this region and expressing the truncated version of the molecule in COS cells (COS.Cyto.Del cells). Electron microscopy demonstrated internalization of gold-labeled anti-TM antibody or thrombin in a time- and temperature-dependent manner, similar to that seen with the wild-type transfected cells (COS.TM-CR). Endocytosis was characterized by initial surface clustering of gold particles, followed by aggregation into noncoated pits, early endosome formation, and, finally, entry into multivesicular bodies and lysosomes. There was a notable absence of gold particles in clathrin-coated pits and vesicles. The kinetics of binding and internalization of 125I-labeled ligand in COS.Cyto.Del cells was compared with that of COS.TM-CR cells and was not significantly different. These studies provide ultrastructural and quantitative data to indicate that TM efficiently undergoes endocytosis via nonclathrin-coated pits when the receptor is lacking the cytoplasmic domain. This finding suggests that there may be alternative regions of the molecule that mediate those signals necessary for internalization.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8106566     DOI: 10.1002/jcp.1041580211

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  8 in total

Review 1.  Thrombomodulin and its role in inflammation.

Authors:  Edward M Conway
Journal:  Semin Immunopathol       Date:  2011-07-31       Impact factor: 9.623

2.  Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity.

Authors:  Y Zhang; H Weiler-Guettler; J Chen; O Wilhelm; Y Deng; F Qiu; K Nakagawa; M Klevesath; S Wilhelm; H Böhrer; M Nakagawa; H Graeff; E Martin; D M Stern; R D Rosenberg; R Ziegler; P P Nawroth
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

Review 3.  Circulating Thrombomodulin: Release Mechanisms, Measurements, and Levels in Diseases and Medical Procedures.

Authors:  Mallorie Boron; Tiffany Hauzer-Martin; Joseph Keil; Xue-Long Sun
Journal:  TH Open       Date:  2022-07-11

4.  A Novel Fucose-binding Lectin from Photorhabdus luminescens (PLL) with an Unusual Heptabladed β-Propeller Tetrameric Structure.

Authors:  Atul Kumar; Petra Sýkorová; Gabriel Demo; Pavel Dobeš; Pavel Hyršl; Michaela Wimmerová
Journal:  J Biol Chem       Date:  2016-10-07       Impact factor: 5.157

5.  Thrombomodulin: a bifunctional modulator of inflammation and coagulation in sepsis.

Authors:  Takayuki Okamoto; Hironobu Tanigami; Koji Suzuki; Motomu Shimaoka
Journal:  Crit Care Res Pract       Date:  2012-02-28

6.  Clathrin polymerization is not required for bulk-phase endocytosis in rat fetal fibroblasts.

Authors:  P Cupers; A Veithen; A Kiss; P Baudhuin; P J Courtoy
Journal:  J Cell Biol       Date:  1994-11       Impact factor: 10.539

Review 7.  Thrombomodulin and the vascular endothelium: insights into functional, regulatory, and therapeutic aspects.

Authors:  Fiona A Martin; Ronan P Murphy; Philip M Cummins
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-19       Impact factor: 4.733

8.  Prognostic Significance of Thrombomodulin mRNA in High-Grade Soft Tissue Sarcomas after 10 years.

Authors:  Kunihiro Asanuma; Tomoki Nakamura; Yumiko Asanuma; Takayuki Okamoto; Takuya Kakimoto; Yuki Yada; Tomohito Hagi; Kouji Kita; Koichi Nakamura; Akihiko Matsumine; Akihiro Sudo
Journal:  Orthop Surg       Date:  2020-10-04       Impact factor: 2.071

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.